Male reproductive health after 3 months from SARS-CoV-2 infection: a multicentric study

    Donatella Paoli, Francesco Pallotti, Antonella Anzuini, Serena Bianchini, Luisa Caponecchia, Anna Carraro, Maria Rosa Ciardi, Fabiana Faja, Cristina Fiori, Daniele Gianfrilli, Andrea Lenzi, Miriam Lichtner, I. Marcucci, Claudio Maria Mastroianni, Gerardo Nigro, Patrizia Pasculli, Carlotta Pozza, Flavio Rizzo, Paola Salacone, A. Sebastianelli, Francesco Lombardo
    TLDR COVID-19 temporarily affects male reproductive health, but sperm and testosterone levels generally return to normal after three months.
    The study investigated the impact of SARS-CoV-2 infection on male reproductive health by examining 80 patients three months post-recovery. Results indicated that while COVID-19 did not cause direct testicular damage, there were transient indirect effects. Semen parameters were within normal ranges, with a mean sperm DNA fragmentation of 14.1%. A small percentage (3.9%) showed positive anti-sperm antibodies in blood serum, and 6.2% had low testosterone levels. Erectile dysfunction was present in 30% of subjects. The study concluded that COVID-19's impact on testicular function was temporary, suggesting that infertile couples might consider delaying parenthood or ART procedures for three months post-recovery.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    1 / 1 results

    Similar Research

    5 / 775 results
      Androgens in SARS-CoV-2 Coronavirus Infections

      research Androgens in SARS-CoV-2 Coronavirus Infections

      5 citations , December 2021 in “Physiological Research”
      Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.
      Endocrinology

      research Endocrinology

      April 2023 in “Clinical Chemistry and Laboratory Medicine”
      The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.